Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001326110-25-000071
Filing Date
2025-05-12
Accepted
2025-05-12 06:46:20
Documents
119
Period of Report
2025-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q ibrx-20250331.htm   iXBRL 10-Q 2648971
2 EX-31.1 ibrx-2025331x10qexhibit311.htm EX-31.1 11328
3 EX-31.2 ibrx-2025331x10qexhibit312.htm EX-31.2 11097
4 EX-32.1 ibrx-2025331x10qexhibit321.htm EX-32.1 5294
5 EX-32.2 ibrx-2025331x10qexhibit322.htm EX-32.2 5018
11 2025 PIPELINE ibrx-20250331_g1.jpg GRAPHIC 75795
  Complete submission text file 0001326110-25-000071.txt   14014261

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT ibrx-20250331.xsd EX-101.SCH 95480
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT ibrx-20250331_cal.xml EX-101.CAL 117461
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT ibrx-20250331_def.xml EX-101.DEF 605067
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT ibrx-20250331_lab.xml EX-101.LAB 1053628
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT ibrx-20250331_pre.xml EX-101.PRE 842707
122 EXTRACTED XBRL INSTANCE DOCUMENT ibrx-20250331_htm.xml XML 1981841
Mailing Address 3530 JOHN HOPKINS COURT SAN DIEGO CA 92121
Business Address 3530 JOHN HOPKINS COURT SAN DIEGO CA 92121 (844) 696-5235
ImmunityBio, Inc. (Filer) CIK: 0001326110 (see all company filings)

EIN.: 431979754 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37507 | Film No.: 25932518
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)